ISIN | LU1001671582 |
---|---|
Valor Number | 23070681 |
Bloomberg Global ID | |
Fund Name | European Smaller Companies Equity Fund Q |
Fund Provider |
T. Rowe Price (Switzerland) GmbH
E-Mail: Zurich_info@troweprice.com Web: https://www3.troweprice.com/usis/corporate/en/home.html |
Fund Provider | T. Rowe Price (Switzerland) GmbH |
Representative in Switzerland |
First Independent Fund Services AG Zürich Phone: +41 44 206 16 40 |
Distributor(s) | T. Rowe Price International Ltd |
Asset Class | Equities |
EFC Category | Equity Advanced Europe Small Cap |
Distribution Policy | Accumulation |
Home Country | Luxembourg |
Issuing Condition | The fund does not charge any issuing commission and/or fees (units are issued at the NAV) |
Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
Investment Strategy *** | To increase the value of its shares, over the long term, through growth in the value of its investments. |
Peculiarities |
Current Price * | 20.48 EUR | 22.11.2024 |
---|---|---|
Previous Price * | 20.11 EUR | 21.11.2024 |
52 Week High * | 22.13 EUR | 01.08.2024 |
52 Week Low * | 18.66 EUR | 28.11.2023 |
NAV * | 20.48 EUR | 22.11.2024 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 49,747,057 | |
Unit/Share Assets *** | 2,468,390 | |
Trading Information SIX |
YTD Performance | +1.14% |
29.12.2023 - 22.11.2024
29.12.2023 22.11.2024 |
---|---|---|
YTD Performance (in CHF) | +1.17% |
29.12.2023 - 22.11.2024
29.12.2023 22.11.2024 |
1 month | -4.66% |
22.10.2024 - 22.11.2024
22.10.2024 22.11.2024 |
3 months | -4.74% |
22.08.2024 - 22.11.2024
22.08.2024 22.11.2024 |
6 months | -6.40% |
22.05.2024 - 22.11.2024
22.05.2024 22.11.2024 |
1 year | +9.93% |
22.11.2023 - 22.11.2024
22.11.2023 22.11.2024 |
2 years | +11.06% |
22.11.2022 - 22.11.2024
22.11.2022 22.11.2024 |
3 years | -27.50% |
22.11.2021 - 22.11.2024
22.11.2021 22.11.2024 |
5 years | +19.28% |
22.11.2019 - 22.11.2024
22.11.2019 22.11.2024 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Bawag Group AG Ordinary Shares | 5.01% | |
---|---|---|
Redcare Pharmacy NV | 3.63% | |
SPIE SA | 3.34% | |
Amplifon SpA Az nom Post Frazionamento | 2.24% | |
Laboratorios Farmaceuticos Rovi SA | 2.18% | |
IMCD NV | 1.94% | |
Croda International PLC | 1.89% | |
Rotork PLC | 1.83% | |
Spirax Group PLC | 1.73% | |
Montana Aerospace AG | 1.72% | |
Last data update | 31.10.2024 |
TER *** | 0.92% |
---|---|
TER date *** | 30.06.2024 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 0.75% |
Ongoing Charges *** | 0.92% |
SRRI ***
|
|
SRRI date *** | 31.10.2024 |
Low Carbon Designation *** | |
---|---|
ESG Rating Overall *** | |
ESG Rating Corporate *** | |
ESG Rating Sovereign *** | |
% AuM H&S Controversies *** |
Avg Carbon Risk Score *** | |
---|---|
Avg Carbon Risk Cat Avg *** | |
% AuM Covered Carbon *** | |
Avg Fossil Fuel Exposure *** | |
Fossil Fuel Cat Avg *** |
Strategy Level 1 *** | |
---|---|
Strategy Level 2 *** | |
Strategy Level 3 *** | |
Exclusions Level 1 *** | |
Exclusions Level 2 *** |